Clinical Trials Directory

Trials / Completed

CompletedNCT03691337

Fascia Iliaca Blocks for Total Hip Arthroplasty

Fascia Iliaca Block for Analgesia in Unilateral Direct Anterior Approach Total Hip Arthroplasty

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
75 (actual)
Sponsor
New York School of Regional Anesthesia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The development of minimal-incision techniques for total hip arthroplasty (THA) with preservation of soft tissue is generally associated with reduction of postoperative pain and increased patient comfort. Although this technique requires a smaller incision than other approaches used for hip surgery, adequate postoperative pain management remains crucial for enhanced recovery and early rehabilitation. The fascia iliaca block (FIB) is commonly used to enhance analgesia after hip replacement surgery, however the effect of FIB volume on analgesia quality and sensory-motor blockade have not been adequately studied. In this study, total postsurgical opioid consumption (morphine equivalents IV in hospital and oral at home) through the first postoperative week will be compared and extent and duration of sensory motor block through the 2-day inpatient stay will be evaluated.

Conditions

Interventions

TypeNameDescription
DRUGMarcaine 0.25 % Injectable SolutionFascia iliaca block with volume 0.11 mL x subject height
DRUGMarcaine 0.25 % Injectable SolutionFascia iliaca block with volume 0.22 mL x subject height
DRUGSodium chlorideFascia iliaca block with volume 0.11 mL x subject height

Timeline

Start date
2018-05-15
Primary completion
2019-11-12
Completion
2019-12-04
First posted
2018-10-01
Last updated
2020-09-10

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT03691337. Inclusion in this directory is not an endorsement.